Reducing the Kidney Uptake of High Contrast CXCR4 PET Imaging Agents via Linker Modifications

Purpose: The C-X-C chemokine receptor 4 (CXCR4) is highly expressed in many subtypes of cancers, notably in several kidney-based malignancies. We synthesized, labeled, and assessed a series of radiotracers based on a previous high contrast PET imaging radiopharmaceutical [⁶⁸Ga]Ga-BL02, wi...

Descripción completa

Detalles Bibliográficos

Autores principales:	Daniel Kwon, Zhengxing Zhang, Jutta Zeisler, Hsiou-Ting Kuo, Kuo-Shyan Lin, Francois Benard
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	MDPI AG 2022-07-01
Colección:	Pharmaceutics
Materias:	positron emission tomography oncology CXCR4 pharmacokinetics nuclear medicine
Acceso en línea:	https://www.mdpi.com/1999-4923/14/7/1502
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!